1004 related articles for article (PubMed ID: 29352461)
1. Clinical and microbiological evaluation of the effect of Lactobacillus reuteri in the treatment of mucositis and peri-implantitis: A triple-blind randomized clinical trial.
Galofré M; Palao D; Vicario M; Nart J; Violant D
J Periodontal Res; 2018 Jun; 53(3):378-390. PubMed ID: 29352461
[TBL] [Abstract][Full Text] [Related]
2. Microbiologic and Clinical Findings of Implants in Healthy Condition and with Peri-Implantitis.
Canullo L; Peñarrocha-Oltra D; Covani U; Rossetti PH
Int J Oral Maxillofac Implants; 2015; 30(4):834-42. PubMed ID: 26252036
[TBL] [Abstract][Full Text] [Related]
3. The effect of orally administered probiotic Lactobacillus reuteri-containing tablets in peri-implant mucositis: a double-blind randomized controlled trial.
Flichy-Fernández AJ; Ata-Ali J; Alegre-Domingo T; Candel-Martí E; Ata-Ali F; Palacio JR; Peñarrocha-Diago M
J Periodontal Res; 2015 Dec; 50(6):775-85. PubMed ID: 25712760
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of the effect of probiotics in the treatment of peri-implant mucositis: a triple-blind randomized clinical trial.
Peña M; Barallat L; Vilarrasa J; Vicario M; Violant D; Nart J
Clin Oral Investig; 2019 Apr; 23(4):1673-1683. PubMed ID: 30151705
[TBL] [Abstract][Full Text] [Related]
5. Probiotic supplements and debridement of peri-implant mucositis: a randomized controlled trial.
Hallström H; Lindgren S; Widén C; Renvert S; Twetman S
Acta Odontol Scand; 2016; 74(1):60-6. PubMed ID: 25953193
[TBL] [Abstract][Full Text] [Related]
6. Reuterinos
Lauritano D; Carinci F; Palmieri A; Cura F; Caruso S; Candotto V
Int J Immunopathol Pharmacol; 2019; 33():2058738419827745. PubMed ID: 30791748
[TBL] [Abstract][Full Text] [Related]
7. Frequency of periodontal pathogens in equivalent peri-implant and periodontal clinical statuses.
Cortelli SC; Cortelli JR; Romeiro RL; Costa FO; Aquino DR; Orzechowski PR; Araújo VC; Duarte PM
Arch Oral Biol; 2013 Jan; 58(1):67-74. PubMed ID: 23127822
[TBL] [Abstract][Full Text] [Related]
8. Short-term clinical and microbiological evaluations of peri-implant diseases before and after mechanical anti-infective therapies.
Máximo MB; de Mendonça AC; Renata Santos V; Figueiredo LC; Feres M; Duarte PM
Clin Oral Implants Res; 2009 Jan; 20(1):99-108. PubMed ID: 19126114
[TBL] [Abstract][Full Text] [Related]
9. Clinical, microbiological, and immunological aspects of healthy versus peri-implantitis tissue in full arch reconstruction patients: a prospective cross-sectional study.
Ata-Ali J; Flichy-Fernández AJ; Alegre-Domingo T; Ata-Ali F; Palacio J; Peñarrocha-Diago M
BMC Oral Health; 2015 Apr; 15():43. PubMed ID: 25888355
[TBL] [Abstract][Full Text] [Related]
10. Impact of heavy smoking on the clinical, microbiological and immunological parameters of patients with dental implants: a prospective cross-sectional study.
Ata-Ali J; Flichy-Fernández AJ; Alegre-Domingo T; Ata-Ali F; Peñarrocha-Diago M
J Investig Clin Dent; 2016 Nov; 7(4):401-409. PubMed ID: 26171870
[TBL] [Abstract][Full Text] [Related]
11. The usage of a lactobacilli probiotic in the non-surgical therapy of peri-implantitis: A randomized pilot study.
Laleman I; Pauwels M; Quirynen M; Teughels W
Clin Oral Implants Res; 2020 Jan; 31(1):84-92. PubMed ID: 31705683
[TBL] [Abstract][Full Text] [Related]
12. In vitro assessment of the effect of probiotic lactobacillus reuteri on peri-implantitis microflora.
Mulla M; Mulla M; Hegde S; Koshy AV
BMC Oral Health; 2021 Aug; 21(1):408. PubMed ID: 34412595
[TBL] [Abstract][Full Text] [Related]
13. The effects of Lactobacillus reuteri probiotics combined with azithromycin on peri-implantitis: A randomized placebo-controlled study.
Tada H; Masaki C; Tsuka S; Mukaibo T; Kondo Y; Hosokawa R
J Prosthodont Res; 2018 Jan; 62(1):89-96. PubMed ID: 28756115
[TBL] [Abstract][Full Text] [Related]
14. Subgingival microbiome in patients with healthy and ailing dental implants.
Zheng H; Xu L; Wang Z; Li L; Zhang J; Zhang Q; Chen T; Lin J; Chen F
Sci Rep; 2015 Jun; 5():10948. PubMed ID: 26077225
[TBL] [Abstract][Full Text] [Related]
15. Periodontal and peri-implant microbiota in patients with healthy and inflamed periodontal and peri-implant tissues.
Zhuang LF; Watt RM; Mattheos N; Si MS; Lai HC; Lang NP
Clin Oral Implants Res; 2016 Jan; 27(1):13-21. PubMed ID: 25399962
[TBL] [Abstract][Full Text] [Related]
16. Systemic antibiotics and debridement of peri-implant mucositis. A randomized clinical trial.
Hallström H; Persson GR; Lindgren S; Olofsson M; Renvert S
J Clin Periodontol; 2012 Jun; 39(6):574-81. PubMed ID: 22571225
[TBL] [Abstract][Full Text] [Related]
17. Probiotic effects of orally administered Lactobacillus reuteri-containing tablets on the subgingival and salivary microbiota in patients with gingivitis. A randomized clinical trial.
Iniesta M; Herrera D; Montero E; Zurbriggen M; Matos AR; Marín MJ; Sánchez-Beltrán MC; Llama-Palacio A; Sanz M
J Clin Periodontol; 2012 Aug; 39(8):736-44. PubMed ID: 22694350
[TBL] [Abstract][Full Text] [Related]
18. Clinical and microbiological effects of Lactobacillus reuteri probiotics in the treatment of chronic periodontitis: a randomized placebo-controlled study.
Teughels W; Durukan A; Ozcelik O; Pauwels M; Quirynen M; Haytac MC
J Clin Periodontol; 2013 Nov; 40(11):1025-35. PubMed ID: 24164569
[TBL] [Abstract][Full Text] [Related]
19. Peri-implant mucositis and peri-implantitis: clinical and histopathological characteristics and treatment.
Khammissa RA; Feller L; Meyerov R; Lemmer J
SADJ; 2012 Apr; 67(3):122, 124-6. PubMed ID: 23198360
[TBL] [Abstract][Full Text] [Related]
20. Primary prevention of peri-implantitis: managing peri-implant mucositis.
Jepsen S; Berglundh T; Genco R; Aass AM; Demirel K; Derks J; Figuero E; Giovannoli JL; Goldstein M; Lambert F; Ortiz-Vigon A; Polyzois I; Salvi GE; Schwarz F; Serino G; Tomasi C; Zitzmann NU
J Clin Periodontol; 2015 Apr; 42 Suppl 16():S152-7. PubMed ID: 25626479
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
